Abbreviation: SRC, steroid receptor coactivator; RAC3, receptor-associated coactivator 3; ANCO-1/2, ankyrin repeats containing cofactors-1/2. 
INTRODUCTION
Nuclear receptors (NRs) are DNA-binding transcription factors that control hormone-dependent gene expression in many biological processes (1, 2) . NRs contain an N-terminal activation domain (AF-1), a central DNA binding domain (DBD), and a C-terminal ligand-binding domain (LBD) that also contains a ligand-dependent activation function (AF-2). Two classes of cofactors, known as coactivators and corepressors, mediate the activation and repression functions of NRs, respectively. Among the corepressors, SMRT and N-CoR are two highly related proteins that bind primarily to unliganded NRs (3) (4) (5) (6) . The mechanism of SMRT/N-CoR mediated transcriptional repression is known to be mediated through histone deacetylases (HDACs) (7) (8) (9) .
Contrary to the corepressors, the p160 NR coactivators bind to liganded NRs to mediate transcriptional activation through recruitment of histone acetyltransferases (HAT) (10) . The p160 coactivators include SRC-1 (11), GRIP1/TIF2 (12) (13) (14) , and RAC3/ACTR/AIB1/pCIP/TRAM-1 (15) (16) (17) (18) (19) . These coactivators bind to the hydrophobic cleft in LBD through LXXLL motifs (20, 21) . These coactivators also interact with histone acetyltransferases (HATs) such as CBP/p300 and P/CAF (22, 23) , tethering HAT activity to target promoters. Genetic studies suggest that the p160 coactivators are involved in regulating hormonal responses in mice (24) (25) (26) . Among the p160 coactivators, RAC3 (AIB1) is clinically important for it is amplified in breast cancers (17) . Furthermore, RAC3 forms a stable complex with ER in breast cancer cells (27) , suggesting that RAC3 may play an important role in the development of breast cancer.
The p160 coactivators share a common domain structure, including a highly conserved N-terminal basic-helix-loop-helix (bHLH) and Per-Arnt-Sim (PAS) domains (10) . The PAS domain is separated into A and B regions, which are conserved among many PAS family proteins (28) . The bHLH-PAS domain is implicated in mediating protein-protein interaction (34) (35) (36) . We thought to search for new proteins that may regulate the function of RAC3 by interacting with the conserved bHLH-PAS domain. Previously, we have identified a human homologue of the yeast MMS19 as a RAC3-interacting protein, which also interacts with ERs in a ligand-independent manner (29). Here, we report the identification and characterization of another RAC3-interacting protein, designated ANCO-1 for ankyrin repeats-containing cofactor-1. We found that ANCO-1 and likely its related protein ANCO-2 may represent a novel class of nuclear receptor corepressors that may inhibit transcriptional activity of NRs through interfering with p160 coactivators' function by recruiting HDACs.
MATERIALS AND METHODS

Plasmids and Yeast Two-hybrid Screen
The bait plasmid pGBT-RAC3 bHLH-PAS (aa 1-408) used in the yeast two-hybrid screen and the other RAC3 constructs are as described previously (15, 30) . A yeast two-hybrid screen of the human placenta cDNA library (Clontech) was conducted in Y190 cells with approximately 2
5
--million transformants. Three RAC3-interacting cDNA clones, RS14, RS2, and RS13 were isolated, and they encode the C-terminal amino acids 2183-2663, 2279-2663, and 2369-2663 of ANCO-1, respectively. The RS2 and RS13 sequences match to a genomic clone on chromosome Xq27.1-Xq27.3; however, the RS14 N-terminal region differs from the genomic sequence. These clones were later found to match exactly to another genomic clone on chromosome 16q24.3 (RP11-781H20) and further analysis indicates that the sequence on Xq27.1 may be a pseudogene. Stepwise search and assembly of many overlapping EST clones in comparison with the genomic sequence predicted a full-length ANCO-1 of approximately 9.1 kilobases. The full-length ANCO-1 vector was constructed using DNA fragments from RS13, the genomic clone PR11-781H20, and the EST clone tf70e12. Constructions of other plasmids were achieved by standard methods and details are available upon requests.
GST Pull-down Assay
GST fusion proteins were expressed in BL-21 cells and purified by standard glutathione agarose beads. The 35 S-methionine labeled proteins were synthesized in reticulocyte lysate (Promega).
Five (5) µg of GST fusion proteins conjugated to glutathione agarose beads were incubated with five (5) µl of in vitro translated proteins at 4°C overnight in a binding buffer as described before (31) . Pellets were washed 4 times with binding buffer and bound proteins eluted in SDS sample buffer followed by SDS-PAGE and autoradiography.
Northern Blot
Multiple Tissue and Cancer Cells Northern blots were purchased from Clontech and probed with 32 P-labeled ANCO-1 cDNA fragments using the ExpressHyb solution. The blot was washed twice for 20 min in 2x SSC /0.1% SDS at room temperature and subject to autoradiography at -70°C.
Immunofluorescence Microscopy
Cells were grown on cover glasses and fixed with cold methanol/acetone (1:1) mixture for 2 minutes and processed for immunofluorescence staining as previously described (32) . Thirty six To investigate whether ANCO-1 also interacts with full-length p160 coactivators, GST pull down assay was conducted using in vitro translated full-length RAC3, TIF2 and SRC-1.
We found that both ANCO-1C and ANCO-1Ct fragment (aa 2597-2663) bound strongly to the full-length RAC3, TIF2, and SRC-1 (Fig. 1C) . These data suggest that ANCO-1C may interact with full-length p160 coactivators through the C-terminal 67 amino acids of ANCO-1. This interaction was further confirmed by mammalian two-hybrid assay in COS-7 cells (Fig. 1D 
Amino Acid Sequences of ANCO-1 and ANCO-2
The full-length ANCO-1 contains 2663 amino acids with an estimated molecular weight of 298 kDa (Fig. 2) . The only known domain in ANCO-1 is the five 33-amino acid-long ankyrin repeats (33) . Interestingly, this ankyrin region is identical to a nasopharyngeal carcinoma susceptibility protein LZ16 (GenBank accession #AF121775), which has a cytosine deleted on codon G326 leading to frame shift and early termination. Comparison of existing EST sequences did not find this deletion in other sequences, suggesting that this mutation might be unique in the nasopharyngeal carcinoma cells. A recent study also showed a partial medulloblastoma antigen sequence corresponding to aa 382-1120 of ANCO-1 but contains a 205 bp-deletion after codon K937 (34), causing a frame shift relative to ANCO-1. Beside ankyrin repeats, ANCO-1 does not contain other noticeable domains. Hydrophobicity analysis shows that the central region of 10 --ANCO-1 is highly charged and contains many putative nuclear localization signals.
Furthermore, an ANCO-1 related protein of unknown function was found in the GenBank (KIAA0874 and GAC-1, GenBank accession # NM_015208 and AF317425). We name this ANCO-1-related protein ANCO-2. The similarity between ANCO-1 and ANCO-2 is most striking at the N-terminal and C-terminal domains (67% and 81%, respectively). ANCO-2 also interacts with p160 coactivators in GST pull down assay (not shown), suggesting that ANCO-1 and ANCO-2 may be functionally related.
Localization of ANCO-1 at Nuclear Foci and Association with HDACs
The interaction of ANCO-1 with transcriptional coactivators suggests that ANCO-1 may be involved in gene regulation. To test this hypothesis, we examined anticipated nuclear localization of ANCO-1 by immunofluorescence staining. HeLa and 293T cells were transfected with HA-ANCO-1 expression vector and double-stained with anti-HA antibodies and antibodies that recognize known nuclear structures. Intriguingly, we found that not only ANCO-specific because ANCO-1 did not colocalize with the nuclear HDAC1 or the cytoplasmic HDAC6.
To investigate the association of ANCO-1 with HDACs, we performed GST pull down assay to determine if ANCO-1 interacts directly or indirectly with HDACs. The data show that the ANCO-1C domain binds to HDAC3 (Fig. 4A) , as well as HDAC4 and HDAC5 (data not shown). The HDAC-interacting domain of ANCO-1 is separable from the coactivator-binding domain because the ANCO-1Ct fragment bound p160 coactivators (Fig. 1C) , but not HDAC3 (Fig. 4A) . Furthermore, co-immunoprecipitation assay also demonstrated the formation of an ANCO-1/HDAC3 protein complex in vivo (Fig. 4B) . These data strongly suggest that, in addition to the p160 coactivators, ANCO-1 may also interact with specific HDACs.
ANCO-1 Inhibits Transcriptional Activation by Nuclear Receptors
The interaction of ANCO-1 with HDACs suggests that ANCO-1 may be a negative cofactor on transcriptional regulation by NRs. To test this hypothesis, we transiently overexpressed ANCO-1 in COS-7 cells and analyzed its effect on ligand-dependent transcriptional activation by NRs.
We found that ANCO-1 overexpression resulted in a concentration-dependent inhibition of ligand-induced transactivation by several NRs, including those for mineralocorticoid (MR), androgen (AR), progesterone (PR), and glucocorticoid (GR) (Fig. 5A, B) . In contrast, ANCO-1 overexpression had no effect on basal activity of the MMTV-Luc reporter (Fig. 5C ). ANCO-1 also had no effect on a Gal4-dependent reporter in the presence of Gal4 DBD or Gal4-VP16 (Fig. 5D) , suggesting that ANCO-1 may inhibit NR-dependent transcription selectively. Furthermore, ANCO-1 expression also inhibited retinoic acid-dependent transactivation of the Gal4-dependent reporter by Gal4-RARα in a concentration-dependent manner (Fig. 5E ). These data strongly suggest that ANCO-1 may function as a negative coregulator for NRs by inhibiting ligand-dependent transcriptional activation.
Finally, we determined the involvement of p160 coactivators on ANCO-1-mediated transcriptional inhibition. We tested whether the inhibition on PR-mediated transactivation by ANCO-1 involves competition with the coactivator TIF2. Consistent with previous experiments, expression of ANCO-1 inhibited PR/progesterone-mediated transactivation on the MMTV-Luc reporter, while expression of TIF2 enhanced the transactivation (Fig. 5F, lanes 3,   4) . Increasing concentrations of ANCO-1 progressively diminished the TIF2-mediated coactivation, suggesting that ANCO-1 may antagonize TIF2's coactivator function. Conversely, increasing concentrations of TIF2 also overcame ANCO-1-mediated transcriptional repression on PR/progesterone-mediated transactivation in a dose-dependent manner (Fig. 5G) .
Consistently, a Gal4 DBD-ANCO-1 fusion protein was able to repress basal transcription of the (34) . Therefore, it is reasonable to speculate that ANCO-1 may serve as a molecular marker for the tumors. The ANCO-1 gene is located at 16q24.3, a region that is frequently deleted in cancer (34, 38) . This finding supports the possibility that ANCO-1 may be a cancer related gene. One striking feature of ANCO-1 is the presence of five ankyrin repeats at the N-terminal region. Ankyrin repeats are 33 amino acids long involved in protein-protein interactions (33) . Indeed, yeast two-hybrid screening using the ANCO-1 ankyrin repeats as bait has discovered several other proteins (Chia-Wei Li, unpublished), suggesting that ANCO-1 may play a role in integrating signals from multiple protein-protein interactions. The core domain of ankyrin repeat adopts a helix-loop-helix structure and the repeats occur in a large number of functionally diverse proteins. Among the five ankyrin repeats, the first repeat is least conserved, and whether it would adopt the normal ankyrin structure is unclear since minimal ankyrin repeats can occur in four consecutive copies.
Immunofluorescence staining of ANCO-1 shows clear nuclear foci localization.
Localization of ANCO-1 in the nucleus is consistent with the presence of multiple nuclear localization signals and its predicted function as a transcriptional coregulator. However, accumulation of ANCO-1 protein in nuclear foci was unexpected, but it provides an opportunity for analyzing in vivo protein-protein interactions through subcellular colocalization. We found that the ANCO-1 nuclear foci are distinct from other known nuclear structures, suggesting that ANCO-1 nuclear foci may represent novel compartments that are likely important for ANCO-1 function. Coexpression of ANCO-1 with RAC3 also shows colocalization (not shown),
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--although RAC3 signal was less consistent due to its rapid degradation (39) . Conceivably, it is possible that ANCO-1 nuclear foci may be associated with DNA-bound NR /coactivator complex, although one cannot rule out the possibility that the ANCO-1 foci might act as protein depots for sequestrating coactivators or corepressors. Clear formation of ANCO-1 nuclear foci can be observed at low levels of ANCO-1 expression and also in stable clones, suggesting that the endogenous ANCO-1 may form nuclear foci.
The facts that ANCO-1 is a nuclear protein associated with p160 coactivators and the revelation that ANCO-1 also binds to HDAC corepressors implicate a potential corepressor function for ANCO-1. Indeed, transient reporter assay establishes a strong inhibition of NRmediated transcriptional activation by ANCO-1 ( 
